View item

US Department of Defense – Neurofibromatosis Research Program (NFRP) – Investigator-Initiated Research Award
Sponsor: US Department of Defense 		Closing Date: 26-Jul-2018
The Neurofibromatosis Research Program seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in neurofibromatosis (NF) research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; promote translational and clinical studies to move promising ideas from bench to bedside; and develop a balanced portfolio of meritorious research related to all aspects of NF type 1 (NF1) and type 2 (NF2), and schwannomatosis. The FY18 NFRP strongly encourages research applications that specifically address the critical needs of the NF community in one or more of the Areas of Emphasis.

The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data.

Eligibility
• Principal Investigator (PI): Must be at or above the level of Assistant Professor (or equivalent) and must plan to commit at least a 10% level of effort for each budget period for the entirety of the award.
• Optional Qualified Collaborator: Must be at or above the level of Assistant Professor (or equivalent) and must plan to contribute at least a 10% level of effort for each budget period for the entirety of the award.

Key Mechanism Elements
• Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.
• Optional Qualified Collaborator: Applications that include a Qualified Collaborator who meets criteria identified in the Program Announcement/Funding Opportunity may apply for a higher level of funding.
• Clinical trials are not allowed.

Funding
• Maximum funding of USD $525,000 for direct costs, plus indirect costs ($575,000 in direct costs if requesting an Optional Qualified Collaborator).
• Maximum period of performance is 3 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/nfrp and http://cdmrp.army.mil/nfrp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Full applications due to UQR&I: 19 July 2018
Pre-applications (mandatory) close with US Department of Defense: 26 July 2018
Full applications close with US Department of Defense: 9 August 2018

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (via internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/nfrp

Return